检查点抑制剂检查点抑制剂
1Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
免疫检查点抑制剂可能导致罕见的血液毒性. 管理这些毒性需要平衡癌症治疗与免疫相关的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 免疫检查点抑制剂 (ICI) 是一种激活免疫细胞抵抗癌症的抗瘤疗法.
- ICI的不良影响很常见,通常与免疫相关,并源于免疫细胞激活和失调.
- 来自ICI的血液毒性很少见,其机制尚未得到充分理解.
研究的目的:
- 审查与免疫检查点抑制剂相关的罕见血液毒性管理的挑战和战略.
- 为了突出管理这些毒性的复杂性,同时继续癌症治疗.
主要方法:
- 免疫检查点抑制剂诱导的血液毒性的文献综述.
- 对罕见的血液学不良事件提出的机制的分析.
- 讨论临床管理策略,平衡瘤和血液护理.
主要成果:
- 血液毒性是ICI治疗的不常见但严重的并发症.
- 机制包括免疫失调,自身抗体的产生和细胞因子的释放.
- 管理需要仔细考虑潜在的恶性瘤和免疫反应.
结论:
- 与ICI相关的血液毒性的管理是复杂的,需要多学科的方法.
- 策略必须保持抗瘤疗效,同时减轻血液学风险.
- 为了优化患者护理,需要对机制进行进一步的研究.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Enzyme Inhibition
78.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
435
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
435
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
Feedback Inhibition
53.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.9K
Dipeptidyl Peptidase 4 Inhibitors
190
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
190


